Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

October 10, 2024

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

CV Risk After Acute COVID-19 Not So High as Feared: Registry

News Daily News

CV Risk After Acute COVID-19 Not So High as Feared: Registry

January 06, 2023

November 2022 News Roundup

News Opinion CV Team Dispatch

November 2022 News Roundup

November 01, 2022

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

News Conference News EACTS 2022

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Michael O'Riordan

October 12, 2022

Myocarditis Risk Low Overall After COVID-19 Vax, but Higher in Some Groups

News Daily News

Myocarditis Risk Low Overall After COVID-19 Vax, but Higher in Some Groups

August 23, 2022

Smoking Linked With Worse Outcomes in Hospitalized COVID-19 Patients

News Daily News

Smoking Linked With Worse Outcomes in Hospitalized COVID-19 Patients

Michael O'Riordan

July 29, 2022

High Lp(a) May Predict Risk of CV and Limb Events in PAD

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

July 18, 2022

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

News Daily News

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

May 20, 2022

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

COVID-19: TCTMD’s Dispatch for May Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for May Week 2

May 09, 2022

February 2022 News Roundup

News Opinion CV Team Dispatch

February 2022 News Roundup

February 01, 2022

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

News Conference News TCT 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

November 04, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

News Daily News

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

June 29, 2021

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

News Daily News

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

June 22, 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

May 16, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.